Focus Biomolecules will be exhibiting at the annual meeting of American Association for Cancer Research (AACR) in San Diego, April 7 – 10. Stop by our
New DUB inhibitor: Deubiquitinating enzymes, or DUBs, are proteases that regulate ubiquitination dynamics. DUBs have become promising targets for drug discovery across diverse therapeutic areas. For
Journal Club: In the January issue of J. Cellular Physiology, Arasaki and Hayata from the Tokyo University of Science studied the mechanisms of nuclear localization of
Journal Club: In the February issue of Nature Cancer, CJ Bergin and coworkers from the University of Ottawa demonstrated that vanoxerine (GBR-12909), a well-known dopamine transporter
Focus will be exhibiting at the BPS Biophysical Society meeting, Feb 11 – 13, 2024, in Philadelphia. Stop by our booth #1008 and chat with our
Focus Biomolecules will be exhibiting at American Society for Cell Biology (ASCB) in Boston, MA, starting December 3, 2023. Stop by our booth #332 and chat
Website Created by Advanta Advertising LLC.
